|
|
|
Saturday, February 26, 2011 — 7:00 p.m., CC 008 A/B
|
- The Evolving Practice of Cytopathology: Morphology, Ancillary Tests and Personalized Medicine
|
|
Moderator:
|
Zubair W. Baloch, Hospital of the University of Pennsylvania,
Philadelphia, PA
|
|
|
Disclosure:
|
In accordance with ACCME guidelines regarding disclosure, the USCAP policy requires that faculty members who have a significant financial or other relationship with a commercial company, entity, or service (which will be discussed in this Symposium) must disclose this to attendees. The Academy also requires that speakers disclose any products that are not labeled for the use under discussion. The speakers listed below have indicated they have nothing to disclose.
|
Click the button above to add this event to your Itinerary Planner...
| 7:00 | Introduction:
- Zubair W. Baloch, Hospital of the University of Pennsylvania,
Philadelphia, PA |
| 7:15 | Practicing Morphology in the Era of Special Techniques
- Sylvia L. Asa, University Health Network, Ontario Cancer Institute,
and University of Toronto, Toronto, Ontario |
| 7:50 | How Much Molecular Pathology Does a Cytopathologist Need to Know?
- Jennifer Hunt, Massachusetts General Hospital, Boston, MA |
| 8:25 | Lessons Learned from Molecular Analysis of "Unbelievably Small" Cytology Specimens
- Dara Aisner, UCD- School of Medicine, Aurora, CO |
| 9:00 | HPV Analysis of Head and Neck Fine-Needle Aspiration Specimens
- William Westra, The Johns Hopkins Medical Institutions, Baltimore,
MD |
| 9:35 | Question and Answer Session |
The PSC and ASC solicited topics of interest from their membership at the annual business meetings. Several potential topics were discussed at the Executive Board meeting and the topic for the 2011 session was chosen in agreement with the chairs of the scientific program committees. Improving the current practice of cytology in the current era of specialized techniques and personalized medicine is of high interest to PSC & ASC membership and is currently cited as an important and the most discussed topic in cytopathology and molecular pathology. The PSC and ASC membership are focused on the dissemination of best practices to improve quality of cytopathology practice and explore the role of various ancillary techniques that may prove beneficial to the cytopathologist.
Our needs assessment process was based on the evaluation of the current literature and the feedback provided by audience participating in our prior companion society sessions.
The purpose and objectives of the program are as follows: 1) Provide a pathologists view of the role of basic morphology in the diagnosis and triage of cytology specimens for ancillary tests. 2) Highlight the role of molecular techniques as an aid to cytopathologic diagnosis. 3) Describe the role of the molecular pathologist in targeted therapy decisions based on small biopsy specimen diagnosis. 4) Discuss known "best-practices" and means of implementation. 5) Provide and illustrate the role of HPV testing of head and neck FNA specimens.
Evaluations through the USCAP are required in order to obtain CME credit. We also will evaluate effectiveness by monitoring attendance and tracking the scope and breadth of questions and the evaluations of each speaker.
|
|
|
|
